Back to results
US 2012/0232101 A1Published application
Novel Compounds
OwnerDavid Chapman, Balint Gabos +1inventors
InventorsDavid Chapman, Balint Gabos, Magnus Munck af Rosenschöld
Life of this patent
Estimating the term…
Abstract
The invention provides compounds of formula (I): wherein R1 and R2 are as defined in the specification; processes for their preparation; pharmaceutical compositions containing them; a process for preparing the pharmaceutical compositions; and their use in therapy. The compounds are useful as MMP inhibitors.
Claims4
1-18. (canceled)
A compound of formula:
- or a pharmaceutically acceptable salt thereof.
A pharmaceutical composition comprising a compound of formula:
- or a pharmaceutically acceptable salt thereof, in association with a pharmaceutically acceptable adjuvant, diluent, or carrier.
A method of treating aortic aneurysm, which comprises administering to a patient a therapeutically effective amount of a compound of formula:
- or a pharmaceutically acceptable salt thereof.
Dependencies are inferred from the claim text.